Article Details

Arcturus Therapeutics Receives Orphan Drug Designation from the U.S. FDA for ARCT-032 ...

Retrieved on: 2023-11-27 13:48:08

Tags for this article:

Click the tags to see associated articles and topics

Arcturus Therapeutics Receives Orphan Drug Designation from the U.S. FDA for ARCT-032 .... View article details on HISWAI: https://www.biospace.com/article/releases/arcturus-therapeutics-receives-orphan-drug-designation-from-the-u-s-fda-for-arct-032-for-the-treatment-of-cystic-fibrosis/

Excerpt

... mRNA Technology (sa-mRNA) and (iii) mRNA drug substance along with drug product manufacturing expertise. The Company has an ongoing global ...

Article found on: www.biospace.com

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up